Neuraxis Inc. (NRXS)

Name: Neuraxis Inc. (NRXS) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Neuraxis Inc. (NRXS)

Stock Card

$6.08

$-1.30 (-17.62%)

As on 27-Aug-2026 12:36EDT

Market cap

$77 Mln

Revenue (TTM)

$5 Mln

P/E Ratio

P/B Ratio

11.7

Div. Yield

0 %

Neuraxis Inc (NRXS) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 5.90 High: 6.15

52 Week Range

Low: 2.21 High: 9.33

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-1.4 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-4.4
Debt to Equity

0
Book Value

$--
EPS

$-0.8
Face value

--
Shares outstanding

12,557,765

Years Aggregate

CFO

$--

EBITDA

$--

Net Profit

$--

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Neuraxis Inc (NRXS)	33.9	--	-17.6	148.2	5.6	--	--
BSE Sensex	-9.1	1.1	1.2	-4.8	5.8	6.6	10.7
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 27-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024
Neuraxis Inc (NRXS)	93.2	-11.9
S&P Small-Cap 600	4.0	7.0
BSE Sensex	9.1	8.1

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Neuraxis Inc (NRXS)	6.1	77.2	5.3	-7.9	-142.5	-155.3	--	11.7
DBV Technologies S.A. - ADR	14.4	914.4	0.0	-175.9	--	-106.8	--	5.6
HUTCHMED (China) - ADR	12.4	2,195.3	549.1	17.9	-6.3	1.4	126.3	1.7
Inventiva Sa (IVA)	4.9	1,105.5	4.5	-340.2	-518.6	501.4	--	2.1
LogicBio Therapeutics (LOGC)	12.6	518.9	0.0	-29.0	0.0	-20.4	--	1.8
Mesoblast - ADR	18.1	2,204.8	65.4	-94.4	-108.2	-16.1	--	3.9
Pharming Group N.V. ADS each representing 10 (PHAR)	11.9	838.7	366.5	9.3	8.3	3.4	84.6	3.1
Prime Medicine	3.6	614.9	4.1	-187.9	-4,613.1	-233.9	--	0.3
Silence Therapeutics PLC (SLN)	13.7	824.8	0.6	-59.9	-9,892.6	-118.9	--	21.3
Zai Lab - ADR	26.8	2,920.0	449.6	-188.2	-41.1	-28.5	--	4.8

Shareholding Pattern

View Details

About Neuraxis Inc (NRXS)

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field... stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana. Read more

President, CEO & Director

Mr. Brian Carrico
President, CEO & Director

Mr. Brian Carrico
Headquarters

Carmel, IN
Website

https://neuraxis.com

FAQs for Neuraxis Inc (NRXS)

What is the current share price of Neuraxis Inc (NRXS) Today?

The share price of Neuraxis Inc (NRXS) is $6.08 (NYSE) as of 27-Aug-2026 12:36 EDT. Neuraxis Inc (NRXS) has given a return of 5.62% in the last 3 years.

What is the current PB & PE ratio of Neuraxis Inc (NRXS)?

Since, TTM earnings of Neuraxis Inc (NRXS) is negative, P/E ratio is not available.
The P/B ratio of Neuraxis Inc (NRXS) is 11.70 times as on 21-Aug-2026, a 143 premium to its peers’ median range of 4.82 times.

PE & PB ratio at the end of financial year.